jcm-logo

Journal Browser

Journal Browser

Announcements

14 July 2025
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026


We cordially invite you to attend the 1st International Online Conference on Hematology organized by the MDPI journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0), and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2). It will take place online from 28 to 30 October 2026, and it is free of charge for all participants.

Conference Chair:

  • Prof. Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

The topics of interest:

S1. Multiple Myeloma;
S2. Acute Myeloid Leukemia;
S3. Acute Lymphoblastic Leukemia;
S4. Non-Hodgkin Lymphoma;
S5. Hodgkin Lymphoma;
S6. CML and Myeloproliferative Neoplasms;
S7. Stem Cell Transplantation and New Cellular Therapies;
S8. Rare diseases.

Important dates:
Deadline for abstract submission:
29 June 2026;
Notification of acceptance: 28 July 2026;
Deadline for registration: 22 November 2026.

Guide for authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1493.

To register for the event, please click on the following link: https://sciforum.net/event/IOCHE2026?subscribe&section=#registration.

Note: We only accept abstracts for this conference. To publish a conference proceedings paper for free and submit a full manuscript to the organizing journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0) and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2), please refer to the Publication Opportunities section.

Best Presentation Award and Best Poster Award:

  • Six winners;
  • Each winner will receive a certificate;
  • CHF 200 each.

For any enquiries regarding this event, please contact ioche2026@mdpi.com.

We look forward to seeing you at the 1st International Online Conference on Hematology!

14 July 2025
Journal of Clinical Medicine | Highly Cited Papers  Published in 2024 and Hot Topic Special Issues in the “Clinical Pediatrics” Section


Our “Clinical Pediatrics” Section of Journal of Clinical Medicine (JCM, ISSN: 2077-0383) was established in 2023, and a total of 394 papers have been published since its launch. The aim of this Section is to offer a platform to pediatric clinicians, physicians, and healthcare professionals to present cutting-edge basic and applied health research, as well as quality clinical services in general and specialty pediatrics. We invite you to explore the highly cited articles of 2024 and discover the latest research via the following link: https://www.mdpi.com/search?journal=jcm&section=2471.

Our “Clinical Pediatrics” Section’s subject areas, including but not limited to the following:

  • Neonatal medicine;
  • Genetic and congenital conditions;
  • Developmental–behavioral medicine;
  • Pediatric surgery;
  • Pediatric cardiology;
  • Pediatric nephrology;
  • Pediatric dermatology;
  • Pediatric orthopedics;
  • Pediatric stomatology;
  • Pediatric infectious diseases;
  • Pediatric pulmonary;
  • Child and adolescent psychiatry;
  • Pediatric neurology;
  • Pediatric ophthalmology;
  • Childhood cancer;
  • Pediatric allergy and immunology;
  • Pediatric endocrinology;
  • Pediatric gastroenterology.

In addition, some Special Issues in the “Clinical Pediatrics” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:

1. Candida auris Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review
by Rozeta Sokou, Alexia Eleftheria Palioura, Paschalia Kopanou Taliaka, Aikaterini Konstantinidi, Andreas G. Tsantes, Daniele Piovani, Konstantina A. Tsante, Eleni A. Gounari, Zoi Iliodromiti, Theodora Boutsikou et al.
J. Clin. Med. 2024, 13(6), 1586; https://doi.org/10.3390/jcm13061586
Full text available online: https://www.mdpi.com/2077-0383/13/6/1586

2. “Occlusal Caries Detection with Intraoral Scanners in Pediatric Dentistry: A Comparative Clinical Study
by Nelly Schulz-Weidner, Marina Gruber, Bernd Wöstmann, Constanze Friederike Uebereck, Norbert Krämer and Maximiliane Amelie Schlenz
J. Clin. Med. 2024, 13(4), 925; https://doi.org/10.3390/jcm13040925
Full text available online: https://www.mdpi.com/2077-0383/13/4/925

3. “Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
by Paola Borgia, Gianluca Piccolo, Andrea Santangelo, Cristina Chelleri, Gianmaria Viglizzo, Corrado Occella, Carlo Minetti, Pasquale Striano and Maria Cristina Diana
J. Clin. Med. 2024, 13(6), 1792; https://doi.org/10.3390/jcm13061792
Full text available online: https://www.mdpi.com/2077-0383/13/6/1792

4. “Ultrasonic Scalpel vs. Polymeric Clip Laparoscopic Varicocelectomy in Adolescents with Symptomatic Varicocele
by Zenon Pogorelić, Karlo Poljak, Miro Jukić and Katarina Vukojević
J. Clin. Med. 2024, 13(15), 4322; https://doi.org/10.3390/jcm13154322
Full text available online: https://www.mdpi.com/2077-0383/13/15/4322

5. “Acute Kidney Injury in Neonatal Intensive Care Unit: Epidemiology, Diagnosis and Risk Factors
by Valeria Chirico, Antonio Lacquaniti, Filippo Tripodi, Giovanni Conti, Lucia Marseglia, Paolo Monardo, Eloisa Gitto and Roberto Chimenz
J. Clin. Med. 2024, 13(12), 3446; https://doi.org/10.3390/jcm13123446
Full text available online: https://www.mdpi.com/2077-0383/13/12/3446

6. “Malnutrition and Allergies: Tipping the Immune Balance towards Health
by Emilia Vassilopoulou, Carina Venter and Franziska Roth-Walter
J. Clin. Med. 2024, 13(16), 4713; https://doi.org/10.3390/jcm13164713
Full text available online: https://www.mdpi.com/2077-0383/13/16/4713

7. “High-Resolution Anorectal Manometry as a Screening Tool for Hirschsprung’s Disease: A Comprehensive Retrospective Analysis
by Oliver Sowulewski, Magdalena Bubińska, Agnieszka Zagierska, Maciej Zagierski and Agnieszka Szlagatys-Sidorkiewicz
J. Clin. Med. 2024, 13(5), 1268; https://doi.org/10.3390/jcm13051268
Full text available online: https://www.mdpi.com/2077-0383/13/5/1268

8. “Artificial Intelligence-Based Diagnostic Support System for Patent Ductus Arteriosus in Premature Infants
by Seoyeon Park, Junhyung Moon, Hoseon Eun, Jin-Hyuk Hong and Kyoungwoo Lee
J. Clin. Med. 2024, 13(7), 2089; https://doi.org/10.3390/jcm13072089
Full text available online: https://www.mdpi.com/2077-0383/13/7/2089

9. “Barriers to Type 1 Diabetes Adherence in Adolescents
by Sarah Azar, Noa Maroun Abou Jaoude, Andrzej Kędzia and Elżbieta Niechciał
J. Clin. Med. 2024, 13(19), 5669; https://doi.org/10.3390/jcm13195669
Full text available online: https://www.mdpi.com/2077-0383/13/19/5669

Special Issues:
Risk Factors in Neonatal Intensive Care
Guest Editors: Prof. Dr. Gabriela C. Zaharie
and Dr. Melinda Matyas
Submission deadline: 20 December 2025
Pediatric Neurosurgery: Clinical Advances in Diagnostics and Perioperative Management
Guest Editors: Dr. Kara Leigh Krajewski and
Prof. Dr. Ulrich-Wilhelm Thomale
Submission deadline: 29 December 2025
Cardiac and Pulmonary Involvements in High-Risk Neonatal Cohorts: Short- and Long-Term Issues
Guest Editor: Prof. Dr. Arvind Sehgal
Submission deadline: 20 January 2026
Endocrine Disorders in Children: 2nd Edition
Guest Editor: Dr. Juan Pedro López-Siguero
Submission deadline: 20 February 2026

7 July 2025
Meet Us at the European Academy of Dermatology & Venereology (EADV) 2025, 17–20 September 2025, Paris, France


Conference: European Academy of Dermatology & Venereology (EADV) 2025
Date: 17–20 September 2025
Location: Paris, France 

MDPI will attend the European Academy of Dermatology & Venereology (EADV) 2025, which will be held from 17 to 20 September 2025, as an exhibitor (booth position—A24). We welcome researchers from various backgrounds to visit our booth and share their latest ideas with us.

It is with great pride and anticipation that we welcome you to the EADV Congress 2025, set against the vibrant backdrop of Paris—a city synonymous with elegance, culture, and innovation. As we gather at the Paris Convention Centre, we unite once again to celebrate the very best in dermatology and venereology.

This year’s Congress promises to be our most dynamic yet. With over 180 scientific sessions, 600+ expert speakers, 25+ dedicated subspecialty tracks, and 10 powerful plenary lectures, our programme reflects the incredible depth and breadth of our field. We are especially excited to host abstract-based free communications, late-breaking research highlights, and a residents-targeted session, ensuring opportunities for every level of expertise and interest.

The following open access journals will be represented at the conference:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have.

7 July 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Liver Diseases


Chronic liver disease is a major global health challenge and has long posed a serious threat to the quality of human life. We sincerely recommend the highly cited papers on liver diseases selected in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in the past two years. Each of them is the result of the hard work and wisdom of elite scientific researchers. These selected papers cover multiple dimensions, such as liver transplantation technology innovation, liver fibrosis, and nonalcoholic fatty liver disease. Medical practitioners and enthusiasts are welcome to read for free. At the same time, the channel for soliciting papers on liver diseases in JCM has been opened. We recommend four hot Special Issues for you, and we look forward to your cutting-edge research and innovative results. For more research on liver diseases, please check: https://www.mdpi.com/search?advanced=(@(title)liver.

1. “Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come
Kristopher P. Croome
J. Clin. Med. 2023, 12(3), 909; https://doi.org/10.3390/jcm12030909
Full text available online: https://www.mdpi.com/2077-0383/12/3/909

2. “Metabolic Disorders in Liver Transplant Recipients: The State of the Art
by Filippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, Pietro Andreone and Stefano Gitto
J. Clin. Med. 2024, 13(4), 1014; https://doi.org/10.3390/jcm13041014
Full text available online: https://www.mdpi.com/2077-0383/13/4/1014

3. “The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
by Iulia Minciuna, Madalina Gabriela Taru, Bogdan Procopet and Horia Stefanescu
J. Clin. Med. 2024, 13(5), 1406; https://doi.org/10.3390/jcm13051406
Full text available online: https://www.mdpi.com/2077-0383/13/5/1406

4. “Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study
by Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova et al.
J. Clin. Med. 2024, 13(3), 919; https://doi.org/10.3390/jcm13030919
Full text available online: https://www.mdpi.com/2077-0383/13/3/919

5. “Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
by Chinmay Bera, Nashla Hamdan-Perez and Keyur Patel
J. Clin. Med. 2024, 13(4), 1046; https://doi.org/10.3390/jcm13041046
Full text available online: https://www.mdpi.com/2077-0383/13/4/1046

6. “Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?
by Sama Anvari and Keith Tsoi
J. Clin. Med. 2024, 13(2), 393; https://doi.org/10.3390/jcm13020393
Full text available online: https://www.mdpi.com/2077-0383/13/2/393

7. “Steatotic Liver Disease and Sepsis Outcomes—A Prospective Cohort Study (SepsisFAT)
by Juraj Krznaric, Neven Papic, Nina Vrsaljko, Branimir Gjurasin, Marko Kutlesa and Adriana Vince
J. Clin. Med. 2024, 13(3), 798; https://doi.org/10.3390/jcm13030798
Full text available online: https://www.mdpi.com/2077-0383/13/3/798

8. “Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
by Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, Dorota Łojko, Sebastian Kraszewski, Ali Ibrahim, Maria Hussey, Adam Deptuła, Żaneta Grzywacz, Alexandre Ternianov et al.
J. Clin. Med. 2024, 13(16), 4857; https://doi.org/10.3390/jcm13164857
Full text available online: https://www.mdpi.com/2077-0383/13/16/4857

9. “Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review
by Dario Di Stasio, Agostino Guida, Antonio Romano, Massimo Petruzzi, Aldo Marrone, Fausto Fiori and Alberta Lucchese
J. Clin. Med. 2024, 13(14), 4012; https://doi.org/10.3390/jcm13144012
Full text available online: https://www.mdpi.com/2077-0383/13/14/4012

10. “The Prognostic Value of a Liver Function Test Using Indocyanine Green (ICG) Clearance in Patients with Multiple Organ Dysfunction Syndrome (MODS)
by Franz Haertel, Sebastian Nuding, Diana Reisberg, Martin Peters, Karl Werdan, P. Christian Schulze and Henning Ebelt
J. Clin. Med. 2024, 13(4), 1039; https://doi.org/10.3390/jcm13041039
Full text available online: https://www.mdpi.com/2077-0383/13/4/1039

Special Issues

Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease
Guest Editor: Dr. Hirsh D. Trivedi
Submission deadline: 20 December 2025

Advances in Hepatitis: Prevention, Treatment, and Global Health Impact
Guest Editors: Dr. Michał Brzdęk, Prof. Dr. Dorota Zarębska-Michaluk and Dr. Krystyna Dobrowolska
Submission deadline: 28 January 2026

Clinical Updates and Personalized Medicine in Hepatocellular Carcinoma and Liver Transplantation
Guest Editor: Dr. Adriano Pellicelli
Submission deadline: 20 February 2026

Current and Emerging Treatment Options in Chronic Liver Diseases
Guest Editor: Dr. Chandana B. Herath
Submission deadline: 28 February 2026

4 July 2025
MDPI’s Newly Launched Journals in June 2025

Six new journals covering a range of subjects launched their inaugural issues in June 2025. We are excited to be able to share with you the newest research rooted in the value of open access. We are pleased to present the latest research and to make it accessible to all.

We extend our sincere thanks to all the Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)
Prof. Dr. Chang-Pu Sun,
China Academy of Engineering Physics, Beijing, China; Computational Science Research Center, China
Editorial | View inaugural issue
quantum information and phenomena; condensed matter physics and statistical physics; atomic, molecular, and optical physics; computational physics and mathematical methods
View journal scope | Submit an article
Prof. Dr. Hualiang Lin,
Sun Yat-sen University, China;
Prof. Dr. Jose L. Domingo,
Universitat Rovira i Virgili, Spain
Editorial | View inaugural issue
green and organic food; green infrastructures; green exercise; environmental impact of the healthcare sector; effects of climate change on human health |
View journal scope | Submit an article
Prof. Dr. Francesco Veglio,
University of L’Aquila, Italy
Editorial | View inaugural issue
ultra-pure substances; water purification; air purification; gas purification; inorganic chemical purification; purification technologies
View journal scope | Submit an article
Prof. Dr. Junxing Zheng,
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
computer-aided design and engineering; artificial intelligence and machine learning; building information modeling (BIM) and digital twins; robotics and automation in construction; smart sensors and Internet of Things (IoT); intelligent control systems and facilities management
View journal scope | Submit an article
Prof. Dr. Assunta Di Vaio,
University of Naples Parthenope, Italy
Editorial | View inaugural issue
sustainability, managerial, and biodiversity accounting; carbon management accounting; corporate social responsibility; artificial intelligence and disclosure
View journal scope | Submit an article
Prof. Dr. Changjun Liu,
Sichuan University, China
Editorial | View inaugural issue
bioeffects of electromagnetic waves; electromagnetic science and engineering; microwave, millimeter-wave, and terahertz technologies; metamaterials and metasurfaces; communication, sensing, and networks; energy, power, and sustainable applications; quantum and emerging technologies; artificial intelligence and advanced fabrication
View journal scope | Submit an article
We wish to thank everyone who has supported the development of open access publishing. If you are interested in launching a new open access journal with us, you are welcome to send an application here.

3 July 2025
Interview with Dr. Gabriela Lima de Melo Ghisi—Winner of the Journal of Clinical Medicine 2024 Young Investigator Award


Dr. Gabriela Lima de Melo Ghisi is a scientist at the University Health Network (UHN) in Canada, with a research focus on implementation of patient education interventions across different chronic disease settings and global access to chronic disease management. Dr. Ghisi has led global initiatives to enhance cardiac health education, including developing and evaluating evidence-based patient education curricula in cardiac rehabilitation (CR) programs across 10 countries. Dr. Ghisi’s proven ability to translate research into practical tools and best practices has shaped CR delivery worldwide, positioning her as a global leader in the field and a key contributor to the success of this project.

We would like to congratulate Dr. Gabriela Lima de Melo Ghisi for winning the JCM 2024 Young Investigator Award. The following is an interview with Dr. Ghisi:


You can access more Journal Awards information via the following link: https://www.mdpi.com/journal/jcm/awards.

JCM Editorial Office

2 July 2025
MDPI INSIGHTS: The CEO's Letter #24 - 2024 Impact Factor & CiteScore, MDPI Summits France & USA, Tu Youyou Award

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s 2024 Impact Factor Highlights

For those of our readers who are new to academic publishing, you may have heard some news in June around the Impact Factor release. Every year, typically in June, Clarivate releases its annual Journal Citation Reports (JCR), which include Journal Impact Factors (JIF). This metric is widely used in academic publishing to reflect the average number of citations received by recent articles in each journal.

While Impact Factor is just one of many indicators of journal influence, it remains a major milestone for authors, editors, and publishers. It’s used to assess journal visibility, researcher recognition, and scholarly reach. Throughout our international meetings and events, it’s clear that the Impact Factor is something many of our authors and editorial board members care about, as it can influence where they choose to submit an article and the funding they receive for their research.

“These results reflect the trust that the scholarly community places in MDPI”

MDPI’s 2024 Impact Factor Highlights

  • 298 MDPI journals received a Journal Impact Factor.
  • 60 journals earned their first-ever Impact Factor
    • To put this in perspective: MDPI’s 60 new journal acceptances into the Web of Science was the second highest number of any publisher in 2024, behind Elsevier and ahead of Springer Nature. Our 87% acceptance rate for journals submitted to Web of Science shows the strength of our editorial process and our proven ability to develop journals aligned with Clarivate’s 24 evaluation criteria.
    • Notably, Textiles, Mathematics, International Journal of Neonatal Screening, Smart Cities, Systems, and Pharmaceutics ranked in the top 10% in their respective categories, highlighting their growing influence and prestige within their academic fields. This shows that high-quality indexing goes beyond visibility; it upholds credibility and trust.
  • 193 MDPI journals are now ranked in the top 50% (Q1/Q2) of their subject categories.
    • What does this mean, and why is it important? Journals are ranked by quartiles within their field, based on their Impact Factor. Q1 represents the top 25% of journals in their category, Q2 the next 25%, and so on. Being in Q1 or Q2 shows that a journal is performing well relative to other journals in its category. Authors and institutions often look at quartile rankings when choosing where to publish – it’s an important indicator of visibility and recognition, within its respective category.
  • 116 of our previously ranked journals increased their Impact Factor.
  • 14 MDPI journals achieved an Impact Factor of 5.0 or higher, suggesting a high degree of influence and visibility.

These results reflect our staff's hard work: from our editorial and production teams to our indexing, communications, and data teams, and beyond. This also reflects the trust that the scholarly community places in MDPI, reinforcing the message that when researchers publish with MDPI, they publish with impact.

Open Access with Impact

As the leading fully open access publisher, our journals have received a total of 18.4 million citations in the Web of Science by the end of 2024, reflecting the growing reach and engagement of research published with MDPI. We are committed to making scientific research freely accessible to everyone, everywhere. With the support of more than 4.2 million contributing authors, we’re proud to support the global shift toward open access.

Further Reading

If you’d like to better understand how journals get indexed and why Impact Factors matter, please read this recent interview with Dr. Constanze Schelhorn (Head of Indexing). It gives you a behind-the-scenes look at the role our indexing team plays in supporting journal indexing and visibility.

You can also read our official news announcement shared last week: MDPI Journals in the 2024 Journal Citation Reports.

Thank you to everyone, from our authors and reviewers to our editors and internal teams, who contributed to the progress of our journal indexing in 2024. We’re continuing to build journals that are recognized and trusted across disciplines.

Impactful Research

MDPI Journals See Continued Growth in 2024 CiteScore Results

Continuing our indexing updates, I’m pleased to share that MDPI has achieved strong results in the latest CiteScore metrics, released on 5 June by Scopus. These results reflect the collective efforts of our editors, reviewers, authors, and internal teams, with their dedication to quality and visibility in scientific publishing. You can read the full announcement here.

2024 Highlights:

  • 322 MDPI journals received a CiteScore (up from 274 last year).
  • 283 journals (88%) are ranked in Q1 or Q2 of their subject categories.
  • 237 journals (85%) saw an increase in their CiteScore compared to last year.
  • 48 journals received a CiteScore for the first time.
  • 39 journals are now placed in the top 10% of their subject areas.

“This growth highlights our commitment to supporting open, trusted science”

What is CiteScore and how is it measured?

CiteScore metrics are developed by Elsevier as an alternative to the Impact Factor. They measure the citation impact of journals and can be accessed freely on Scopus. The metric represents the yearly average number of citations to recent articles published in a journal. If you’re interested in learning more about citation metrics and how we use them, check out this blog post.

Why is this important?

These results show the growing recognition for, and impact of, MDPI journals across disciplines. CiteScore rankings help researchers, institutions, and funders assess where high-quality work is being published. This growth improves our journals’ positioning in the publishing landscape and highlights our commitment to supporting open, trusted science.

Inside MDPI

Highlights from the MDPI USA Summit in Boston (5–6 June)

With several Summits already behind us, I think this is a good time to reflect on the purpose of these Summits.

Why do we organize MDPI Summits?

These one-and-a-half-day, invite-only gatherings are designed to improve our relationships with Chief Editors who lead our journals and are respected voices in their fields. The Summits aim to:

  1. Share MDPI’s values, achievements, editorial practices, and local market collaborations.
  2. Collect feedback on MDPI operations and journal practices.
  3. Empower Chief Editors to confidently represent MDPI beyond the Summit.

While Chief Editors know their journals well, these events help them better understand MDPI. We want them to be ambassadors for our brand. The aim is for them to walk away informed, engaged, and equipped to share positively about MDPI.

About the Boston Summit

Held on 5–6 June, our first USA Summit gathered over 25 Chief Editors to learn more about MDPI’s activities and collaborations in the USA. The program included presentations, Q&A, and a panel discussion.

Agenda Highlights:

Moderated by Summer Huggard (Operations Manager [Toronto], MDPI), the program featured:

  • MDPI Overview and USA Collaboration – Stefan Tochev (CEO, MDPI)
  • AI in Publishing and MDPI's Actions – Feichi Lu (Junior Data Scientist, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Feichi, Giulia, Claudia
  • Society Partnerships – Dr. Clàudia Aunós (Society Partnerships Senior Manager, MDPI)
  • Voice of the Customer and Closing Remarks – Stefan Tochev (CEO, MDPI)

MDPI & the USA: Facts and Figures

  • With over 216,000 publications, the USA is MDPI’s second-largest contributor after China.
  • In 2024, the USA ranked 2nd in total submissions and 2nd in total MDPI publications, with more than 28,200 publications.
  • As of 2020, the cumulative number of authors from the USA until April 2025 was 352,099.
  • As at April 2025, there are more than 12,035 active Editorial Board Members (EBMs) from the USA, with 55% having an H-index over 26.
  • Among them, 96 serve as Editors-in-Chief (EiC) and 218 as section-Editors-in-Chief (SEiC)
  • MDPI has more than 920 Institutional Open Access Program agreements worldwide, with over 130 from the USA.

A special thanks to our Toronto team, and everyone who worked behind the scenes to make this event run smoothly.

Coming Together for Science

Highlights from the MDPI France Summit in Paris (12–13 June)

We completed our first MDPI France Summit in Paris last week, and it was a special event. Attendees were engaged from beginning to end, remaining after hours to network and collaborate.

Why a France Summit?

We chose to host a France Summit in view of the recent challenges MDPI has faced with the National Centre for Scientific Research (CNRS). What we took away from the event is that our authors and editors very much appreciate and enjoy working with us, but we need to address the concerns raised by CNRS, around Article Processing Charges (APCs) and the funding of gold open access publications.

“Our authors and editors very much enjoy working with us”

Some of the claims made in the June 2023 interview with Alain Schuhl, the Deputy CEO for Science at the CNRS, are simply not factual. For example, they state that MDPI’s “average APC charges per article are now around the same as Springer Nature’s.” Here is the relevant passage, reproduced verbatim:

This is not accurate.

A recent preprint analysing APC data from Elsevier, Springer Nature, Wiley, PLOS, MDPI, and Frontiers (2019–2023) shows that MDPI’s average APCs remain significantly lower than those of Springer Nature and several other major publishers.

The MDPI Summits are part of our outreach and communication efforts to address misconceptions and clarify MDPI’s position as one of the most accessible and affordable major gold open access publishers in the world.

Summit Overview

Held on 12–13 June, the France Summit gathered over 20 Chief Editors to learn more about MDPI’s activities and collaborations in France. Many of these editors are influential in their institutions and professional societies. Several also have connections to CNRS, which makes this an important opportunity to clarify how we operate and build trust through open and transparent communication and hopefully turn our editors into informed advocates of MDPI.

Summit Feedback

The feedback has been very positive, with most attendees completing the post-event survey and all rating the experience as Excellent or Good. A few highlights:

  • “The whole thing was highly professional and, above all, provided quantified details that will allow us to better answer questions surrounding MDPI.”
  • “The summit was an opportunity to meet personally various people directly engaged in the organization and policies of MDPI, which made it possible to clarify some important points concerning publishing with MDPI.”
  • “Very well organized! A great opportunity to see all French MDPI partners and editors.”

Program Highlights:

Moderated by Miruna Adelina Nicolcioiu (Senior Conference Producer), the program featured:

  • MDPI Overview and France Collaboration – Stefan Tochev (CEO)
  • MDPI Editorial Process and Peer-Review Quality – Dr. Marta Colomer (Public Affairs Specialist)
  • Institutional Partnerships and Open Access Funding Models – Becky Castellon (Institutional Partnerships Manager)
  • AI in Publishing and MDPI's Actions – Daniele Raimondi (Data Scientist)
  • Publication Ethics: Global Trends – Diana Cristina Apodaritei (Research Integrity Specialist)
  • Closing Remarks – Stefan Tochev
  • Panel Discussion – Diana, Becky, Prof. Dr. Patrick Da Cost, and Stefan

MDPI & France: Facts and Figures

  • With over 51,000 publications, France is MDPI's tenth-largest contributor, and fifth largest among EU countries after Italy, Spain, Germany, and Poland.
  • As of 2020, the cumulative number of authors from France until April 2025 was 87,592.
  • As at April 2025, there are more than 2,800 active Editorial Board Members (EBMs) from France, with 59% having an H-index over 26.
  • Among them, 22 serve as Editors-in-Chief (EiC) and 61 as section-Editors-in-Chief (SEiC)
  • In 2024, IJMS, JCM, and Molecules were the top three MDPI journals in terms of submissions from French-affiliated authors.

Special thanks to our colleagues from Romanian offices for organizing this successful event.

Closing Thoughts

Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award

As we wrap up this month’s newsletter, I’d like to take a moment to recognize the winners of the 2024 Tu Youyou Award, presented by our journal Molecules. I am pleased to share that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

I invite you to read the editorial co-authored by the Tu Youyou Award Committee, which highlights the significance of the award and the remarkable impact of the recipients’ research.

A sincere thank-you to the 2024 Award Committee for their dedication and selection process, and congratulations once again to this year’s honourees. Your work exemplifies the kind of research MDPI is proud to support and amplify.

About the Tu Youyou Award
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honour the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award recognizing exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 June 2025
Journal of Clinical Medicine | Selected Feature Papers Published in 2024


We are pleased to present the list of selected feature papers in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2024. JCM received its 2024 Impact Factor (2.9), ranked 65/332 (Q1) in the “Medicine, General & Internal” category. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields.

To learn more about the latest research; please check: https://www.mdpi.com/search?q=&journal=jcm&sort=pubdate&page_count=50.

1. “Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective”
by Pierachille Santus, Juan Camilo Signorello, Fiammetta Danzo, Giada Lazzaroni, Marina Saad and Dejan Radovanovic
J. Clin. Med. 2024, 13(14), 4127; https://doi.org/10.3390/jcm13144127
Full text available online: https://www.mdpi.com/2077-0383/13/14/4127

2. ”Pituitary Apoplexy: An Updated Review”
by Pedro Iglesias
J. Clin. Med. 2024, 13(9), 2508; https://doi.org/10.3390/jcm13092508
Full text available online: https://www.mdpi.com/2077-0383/13/9/2508

3. ”Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study”
by Angel L Montejo, Froilán Sánchez-Sánchez, Rubén De Alarcón, Juan Matías, Benjamin Cortés, Claudia Matos, Tomás Martín-Pinto, Peñitas Ríos, Nerea González-García and José María Acosta
J. Clin. Med. 2024, 13(2), 546; https://doi.org/10.3390/jcm13020546
Full text available online: https://www.mdpi.com/2077-0383/13/2/546

4. ”The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study”
by Nora Schwegel, David Zach, Alexander Peikert, Viktoria Santner, Viktoria Höller, Johannes Gollmer, Johannes Späth, Hermann Riepl, Peter P. Rainer, Markus Wallner et al.
J. Clin. Med. 2024, 13(7), 1930; https://doi.org/10.3390/jcm13071930
Full text available online: https://www.mdpi.com/2077-0383/13/7/1930

5. ”Early-Onset Colorectal Cancer: Are Neuroendocrine Tumors or Adenocarcinomas the Culprit? Analysis of the Largest U.S. Cancer Incidence Database, 2001–2020”
by Yazan Abboud, Madison Fraser, Imran Qureshi and Kaveh Hajifathalian
J. Clin. Med. 2024, 13(4), 1098; https://doi.org/10.3390/jcm13041098
Full text available online: https://www.mdpi.com/2077-0383/13/4/1098

6. ”A Cohort of 469 Mayer–Rokitansky–Küster–Hauser Syndrome Patients—Associated Malformations, Syndromes, and Heterogeneity of the Phenotype”
by Martin Pietzsch, Birgitt Schönfisch, Alice Höller, André Koch, Annette Staebler, Katharina Dreser, Kristina Bettecken, Lisa Schaak, Sara Yvonne Brucker and Katharina Rall
J. Clin. Med. 2024, 13(2), 607; https://doi.org/10.3390/jcm13020607
Full text available online: https://www.mdpi.com/2077-0383/13/2/607

7. ”Entero-Cutaneous and Entero-Atmospheric Fistulas: Insights into Management Using Negative Pressure Wound Therapy”
by Gilda Pepe, Maria Michela Chiarello, Valentina Bianchi, Valeria Fico, Gaia Altieri, Silvia Tedesco, Giuseppe Tropeano, Perla Molica, Marta Di Grezia and Giuseppe Brisinda
J. Clin. Med. 2024, 13(5), 1279; https://doi.org/10.3390/jcm13051279
Full text available online: https://www.mdpi.com/2077-0383/13/5/1279

8. ”Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond”
by Giacomo Tondo, Fabiola De Marchi, Francesca Bonardi, Federico Menegon, Gaia Verrini, Davide Aprile, Matteo Anselmi, Letizia Mazzini and Cristoforo Comi
J. Clin. Med. 2024, 13(11), 3098; https://doi.org/10.3390/jcm13113098
Full text available online: https://www.mdpi.com/2077-0383/13/11/3098

9. ”Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications”
by Nicola Pierucci, Marco Valerio Mariani, Domenico Laviola, Giacomo Silvetti, Pietro Cipollone, Antonio Vernile, Sara Trivigno, Vincenzo Mirco La Fazia, Agostino Piro, Fabio Miraldi et al.
J. Clin. Med. 2024, 13(10), 2980; https://doi.org/10.3390/jcm13102980
Full text available online: https://www.mdpi.com/2077-0383/13/10/2980

10. ”Diagnosis of Pulmonary Embolism: A Review of Evidence-Based Approaches”
by Sneha E. Thomas, Ido Weinberg, Robert M. Schainfeld, Kenneth Rosenfield and Gaurav M. Parmar
J. Clin. Med. 2024, 13(13), 3722; https://doi.org/10.3390/jcm13133722
Full text available online: https://www.mdpi.com/2077-0383/13/13/3722

11. ”Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care”
by Javier De Miguel-Díez, Alberto Fernández-Villar, Esperanza Doña Díaz, Marta Padilla Bernáldez, Eva Trillo-Calvo, Jesús Molina París, Miriam Barrecheguren, José Miguel Valero Pérez and María Teresa Ramírez Prieto
J. Clin. Med. 2024, 13(2), 303; https://doi.org/10.3390/jcm13020303
Full text available online: https://www.mdpi.com/2077-0383/13/2/303

12. ”Multi-Modal Prehabilitation in Thoracic Surgery: From Basic Concepts to Practical Modalities”
by Marc Licker, Diae El Manser, Eline Bonnardel, Sylvain Massias, Islem Mohamed Soualhi, Charlotte Saint-Leger and Adrien Koeltz
J. Clin. Med. 2024, 13(10), 2765; https://doi.org/10.3390/jcm13102765
Full text available online: https://www.mdpi.com/2077-0383/13/10/2765

25 June 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Asthma


The complexity of asthma as a chronic respiratory disease makes achieving a cure challenging, but medical researchers are continuously exploring new avenues for treatment. We invite you to explore the esteemed collection of highly cited articles on asthma that have been published in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) over the past two years, and we hope that they can provide you with new insights. We are currently accepting submissions for Special Issues focusing on asthma, and we look forward to your contributions.

1. “A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma
by Keiji Oishi, Kazuki Hamada, Yoriyuki Murata, Kazuki Matsuda, Syuichiro Ohata, Yoshikazu Yamaji, Maki Asami-Noyama, Nobutaka Edakuni, Tomoyuki Kakugawa, Tsunahiko Hirano et al.
J. Clin. Med. 2023, 12(8), 2900; https://doi.org/10.3390/jcm12082900
Full text available online: https://www.mdpi.com/2077-0383/12/8/2900

2. “Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
by Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, Caterina Tinello, Luca Gallelli, Nicola Lombardo, Rosa Terracciano and Alessandro Vatrella
J. Clin. Med. 2023, 12(10), 3371; https://doi.org/10.3390/jcm12103371
Full text available online: https://www.mdpi.com/2077-0383/12/10/3371

3. “Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
by Laura Diego Bagnasco Pini, Bianca Beghè, Fulvio Braido, Paolo Cameli, Marco Caminati, Cristiano Caruso, Claudia Crimi, Gabriella Guarnieri, Manuela Latorre et al.
J. Clin. Med. 2024, 13(10), 3013; https://doi.org/10.3390/jcm13103013
Full text available online: https://www.mdpi.com/2077-0383/13/10/3013

4. “Severe Asthma and Biological Therapies: Now and the Future
by Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina and Manuel Sanchez-Solis
J. Clin. Med. 2023, 12(18), 5846; https://doi.org/10.3390/jcm12185846
Full text available online: https://www.mdpi.com/2077-0383/12/18/5846

5. “Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes
by Giuseppe Guida, Francesca Bertolini, Vitina Carriero, Stefano Levra, Andrea Elio Sprio, Martina Sciolla, Giulia Orpheu, Elisa Arrigo, Stefano Pizzimenti, Giorgio Ciprandi et al.
J. Clin. Med. 2023, 12(17), 5447; https://doi.org/10.3390/jcm12175447
Full text available online: https://www.mdpi.com/2077-0383/12/17/5447

6. “Asthma Phenotypes in the Era of Personalized Medicine
by Victor Gonzalez-Uribe, Sergio J. Romero-Tapia and Jose A. Castro-Rodriguez
J. Clin. Med. 2023, 12(19), 6207; https://doi.org/10.3390/jcm12196207
Full text available online: https://www.mdpi.com/2077-0383/12/19/6207

7. “Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma””
by Giovanna Elisiana Carpagnano, Andrea Portacci, Silvano Dragonieri, Francesca Montagnolo, Ilaria Iorillo, Ernesto Lulaj, Leonardo Maselli, Enrico Buonamico and Vitaliano Nicola Quaranta
J. Clin. Med. 2024, 13(8), 2320; https://doi.org/10.3390/jcm13082320
Full text available online: https://www.mdpi.com/2077-0383/13/8/2320

8. “Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
by Francesco Menzella
J. Clin. Med. 2023, 12(4), 1546; https://doi.org/10.3390/jcm12041546
Full text available online: https://www.mdpi.com/2077-0383/12/4/1546

9. “Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study
by Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, Yoshihiro Mori, Junko Itano, Akihiko Taniguchi, Satoru Senoo, Goro Kimura, Yasushi Tanimoto, Kohei Miyake et al.
J. Clin. Med. 2023, 12(16), 5174; https://doi.org/10.3390/jcm12165174
Full text available online: https://www.mdpi.com/2077-0383/12/16/5174

10. “Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting
by Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D’Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino and Alessandro Vatrella
J. Clin. Med. 2023, 12(3), 985; https://doi.org/10.3390/jcm12030985
Full text available online: https://www.mdpi.com/2077-0383/12/3/985

Special Issues
Advances in Allergic Diseases and Asthma: Clinical Insights and Emerging Therapies
Guest Editor: Prof. Dr. Zenon Brzoza
Submission deadline: 20 October 2025
Respiratory Medicine in the Oldest-Old
Guest Editor: Dr. Takae Ebihara
Submission deadline: 25 October 2025

New Clinical Advances in Pediatric Asthma
Guest Editor: Prof. Dr. Davor Plavec
Submission deadline: 15 December 2025

Advances in Pulmonary Disease Management and Innovation in Treatment
Guest Editors: Dr. Monica Steluța Marc and
Prof. Dr. Florin Mihaltan
Submission deadline: 15 January 2026

23 June 2025
Journal of Clinical Medicine Travel Award—Open for Applications


We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will be granting a Travel Award to two junior scientists for the year 2026. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the JCM Editorial Board. 

This award provides financial support for the winners to attend an international conference in the field of clinical medicine to be held in 2026, in order to hold a presentation, present a poster, or both.

Candidate requirements:

  • Postdoctoral fellows or Ph.D. students;
  • Plans to attend an international conference in 2026 (oral presentation or poster). 

Required application documents:

  • Information about the conference the applicant is planning to attend and the abstract that will be submitted;
  • Curriculum vitae and list of publications;
  • Justification letter describing the focus of the research (max. 800 words);
  • Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.

The winners (two awardees) will each be awarded CHF 800 and an electronic certificate. 

Please submit your applications for the JCM 2026 Travel Award online by 31 December 2025. Prizes will be awarded at the end of January 2026 and announced on the JCM website.

You can find more information about this award and how to nominate here. To request further information, please contact the JCM Editorial Office.

Journal of Clinical Medicine Editorial Office

Back to TopTop